98%
921
2 minutes
20
Background And Purpose: We aimed to systematically review studies of crosswalks for converting patient-reported outcome measure (PROM) scores used in joint replacement, and develop a database of published crosswalks.
Methods: 4 electronic databases were searched from January 2000 to May 2023 to identify studies reporting the development and/or validation of crosswalks to convert PROM scores in patients undergoing elective hip, knee, or shoulder replacement surgery. Data on study and sample characteristics, source and target PROMs, and crosswalk development and validation methods were extracted from eligible studies. Study reporting was evaluated using the Mapping onto Preference-based measures reporting Standards (MAPS) checklist.
Results: 17 studies describing 35 crosswalks were eligible for inclusion. Unidirectional crosswalks were available to convert hip-specific (Oxford Hip Score [OHS]) and knee-specific (Oxford Knee Score [OKS]) scores to the EQ-5D-3L/EQ-5D-5L. Similar crosswalks to convert disease-specific scores (WOMAC) to the EQ-5D-3L, EQ-5D-5L, and ICECAP-O Capability Index were identified. Bidirectional crosswalks for converting OHS and OKS to the HOOS-JR/HOOS-12 and KOOS-JR/KOOS-12, for converting WOMAC to the HOOS-JR/KOOS-JR, and for converting HOOS-Function/KOOS-Function to the PROMIS-Physical Function were also available. Additionally, crosswalks to convert generic PROM scores from the UCLA Activity Scale to the Lower Extremity Activity Scale in both directions were available. No crosswalks were identified for converting scores in shoulder replacement. Development methods varied with the type of target score; most studies used regression, item response theory, or equipercentile equating approaches. Reporting quality was variable, particularly for methods and results items, impacting crosswalk application.
Conclusion: This is the first synthesis of published crosswalks for converting joint-specific (OHS, OKS, HOOS, KOOS), disease-specific (WOMAC), and generic PROMs scores (PROMIS-Physical Function, UCLA Activity Scale, Lower Extremity Activity Scale) used to assess joint replacement outcomes, providing a resource for data harmonization and pooled analysis. Crosswalks were developed using regression methods (9 studies), equipercentile equating methods (5 studies), a combination of equipercentile equating and item response theory methods (2 studies), and a combination of regression and equipercentile equating methods (1 study). A range of crosswalk validation approaches were adopted, including the use of external datasets, separate samples or subsets, follow-up data from additional time points, or bootstrapped samples. Efforts are needed to standardize crosswalk methodology and achieve consistent reporting.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11494241 | PMC |
http://dx.doi.org/10.2340/17453674.2024.41384 | DOI Listing |
Gastro Hep Adv
February 2025
The Global MASH Council, Washington, District of Columbia.
Background And Aims: The EuroQol-5D (EQ-5D) is a commonly used measure of health utilities to calculate quality-adjusted life years. For the clinical trials that use Chronic Liver Disease Questionnaire-nonalcoholic fatty liver disease (CLDQ-NAFLD) or Short Form-36 (SF-36), ability to convert the health-related quality of life scores (CLDQ-NAFLD or SF-36) to EQ-5D scores provides a valuable method to estimate health utility.
Methods: Baseline data of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) patients were used in this study.
Med Decis Making
August 2025
Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
ObjectivesThe EQ-5D-5L and Patient-Reported Outcomes Measurement Information System (PROMIS®) preference score (PROPr) are preference-based measures. This study compares mapping and linking approaches to align the PROPr and the PROMIS domains included in PROPr plus Anxiety with EQ-5D-5L item responses and preference scores.MethodsA general population sample of 983 adults completed the online survey.
View Article and Find Full Text PDFJ Clin Epidemiol
August 2025
Department of Research and development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands; Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands. Electronic address:
Objectives: Across patient-reported outcome measures (PROMs), the European Organization of Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) is one of the most widely used among patients with cancer. Patients may also complete other PROMs such as forms of the Patient-Reported Outcomes Measurement Information System (PROMIS®). The objective of this study was to develop crosswalks between the EORTC QLQ-C30 physical, role, social and emotional functioning, fatigue and global health status/quality of life (QoL) scales and their corresponding PROMIS® scales.
View Article and Find Full Text PDFEur Spine J
July 2025
Schulthess Klinik, Zurich, Switzerland.
In 1998, an international and multidisciplinary group of experts (from the fields of spine surgery, physiotherapy, occupational therapy, rheumatology, primary care medicine, internal medicine, health economics and epidemiology) proposed a short multidimensional series of core outcome items for use in patients with low back disorders. In 2005 and 2006, two independent research groups published studies validating these items when combined to form an outcome instrument that was subsequently coined the Core Outcome Measures Index for the back (COMI-back). It now exists in at least 22 languages, is used as the primary outcome measure in numerous research studies, and has been adopted by International and National Surgical and Non-Surgical Spine Registries.
View Article and Find Full Text PDFIn 1998, an international and multidisciplinary group of experts (from the fields of spine surgery, physiotherapy, occupational therapy, rheumatology, primary care medicine, internal medicine, health economics and epidemiology) proposed a short multidimensional series of core outcome items for use in patients with low back disorders. In 2005 and 2006, two independent research groups published studies validating these items when combined to form an outcome instrument that was subsequently coined the Core Outcome Measures Index for the back (COMI-back). It now exists in at least 22 languages, is used as the primary outcome measure in numerous research studies, and has been adopted by International and National Surgical and Non-Surgical Spine Registries.
View Article and Find Full Text PDF